BC Week In Review | Dec 9, 2013
Company News

Hexim Pharmaceuticals, Laboratoires Bailleul, Sinclair IS Pharma sales and marketing update

Sinclair said it divested non-core products Effederm , Xclair , Salinum and Numoisyn ( SST ) for £1.1 million ($1.8 million) in cash. Laboratoires Bailleul acquired acne treatment Effederm, which had £300,000 ($485,910) in revenues for the year ended...
Items per page:
1 - 1 of 1